T1	PROC 44 59	Estudio clínico
#1	AnnotatorNotes T1	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T2	PROC 65 84	evaluar la eficacia
#2	AnnotatorNotes T2	C1707887; Efficacy Study; Research Activity
T3	CHEM 88 99	fosfomicina
#3	AnnotatorNotes T3	C0016610; fosfomycin; Antibiotic · Organic Chemical
T4	CHEM 103 112	meropenem
#4	AnnotatorNotes T4	C0066005; meropenem; Antibiotic · Organic Chemical
T5	CHEM 115 126	ceftriaxona
#5	AnnotatorNotes T5	C0007561; ceftriaxone; Antibiotic · Organic Chemical
T6	PROC 133 144	tratamiento
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 151 183	bacteriemia por Escherichia coli
T8	PROC 306 325	evaluar la eficacia
#7	AnnotatorNotes T8	C1707887; Efficacy Study; Research Activity
T9	CHEM 329 340	fosfomicina
#8	AnnotatorNotes T9	C0016610; fosfomycin; Antibiotic · Organic Chemical
T10	CHEM 344 353	meropenem
#9	AnnotatorNotes T10	C0066005; meropenem; Antibiotic · Organic Chemical
T11	CHEM 356 367	ceftriaxona
#10	AnnotatorNotes T11	C0007561; ceftriaxone; Antibiotic · Organic Chemical
T12	PROC 374 394	tratamiento dirigido
#11	AnnotatorNotes T12	C2985566; Targeted Therapy; Therapeutic or Preventive Procedure
T13	DISO 401 453	infección urinaria bacteriémica por Escherichia coli
T14	ANAT 507 513	sangre
#12	AnnotatorNotes T14	C0005767; Blood; Body Substance
T15	ANAT 537 552	tracto urinario
#13	AnnotatorNotes T15	C0042027; Urinary tract; Body Part, Organ, or Organ Component | C1280341; Entire urinary tract; Body System
T16	DISO 599 651	Infección urinaria bacteriémica por Escherichia coli
T17	PROC 731 745	hospitalizados
#14	AnnotatorNotes T17	C0019993; Hospitalization; Health Care Activity
T18	DISO 750 792	bacteriemia de origen urinario por E. coli
T19	ANAT 772 780	urinario
#15	AnnotatorNotes T19	C1508753; Urinary system; Body System
T20	CHEM 820 831	fosfomicina
#16	AnnotatorNotes T20	C0016610; fosfomycin; Antibiotic · Organic Chemical
T21	CHEM 834 843	meropenem
#17	AnnotatorNotes T21	C0066005; meropenem; Antibiotic · Organic Chemical
T22	PROC 875 886	hemocultivo
#18	AnnotatorNotes T22	C0200949; Blood culture; Laboratory Procedure
T23	DISO 932 938	sepsis
#19	AnnotatorNotes T23	C0243026; Sepsis; Disease or Syndrome
T24	DISO 981 992	bacteriemia
#20	AnnotatorNotes T24	C0004610; Bacteremia; Disease or Syndrome
T25	ANAT 1004 1012	urinario
#21	AnnotatorNotes T25	C1508753; Urinary system; Body System
T26	PROC 1039 1070	tratamiento por vía intravenosa
T27	PROC 1153 1170	test de gestación
T28	DISO 1281 1307	Bacteriemia polimicrobiana
#22	AnnotatorNotes T28	C0238748; BACTEREMIA, POLYMICROBIAL; Disease or Syndrome
T29	DISO 1311 1324	Absceso renal
#23	AnnotatorNotes T29	C0151465; Renal abscess; Acquired Abnormality
T30	PROC 1328 1335	drenado
#24	AnnotatorNotes T30	C0013103; Drainage procedure; Therapeutic or Preventive Procedure
T31	DISO 1338 1368	obstrucción de la vía urinaria
#25	AnnotatorNotes T31	C0178879; Urinary tract obstruction; Disease or Syndrome
T32	PROC 1215 1251	consentimiento informado por escrito
#26	AnnotatorNotes T32	C0811741; Obtain informed written consent; Health Care Activity
T33	DISO 1384 1402	Infección urinaria
#27	AnnotatorNotes T33	C0042029; Urinary tract infection; Disease or Syndrome
T34	DISO 1441 1450	infección
T35	DISO 1468 1487	Poliquistosis renal
#28	AnnotatorNotes T35	C0022680; Polycystic Kidney Diseases; Disease or Syndrome
T36	PROC 1492 1508	Trasplante renal
#29	AnnotatorNotes T36	C0022671; Kidney Transplantation; Therapeutic or Preventive Procedure
T37	DISO 1513 1520	Alergia
#30	AnnotatorNotes T37	C1527304; Allergic Reaction; Pathologic Function
T38	DISO 1523 1540	hipersensibilidad
#31	AnnotatorNotes T38	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T39	CHEM 1557 1566	meropenem
#32	AnnotatorNotes T39	C0066005; meropenem; Antibiotic · Organic Chemical
T40	CHEM 1569 1580	ceftriaxona
#33	AnnotatorNotes T40	C0007561; ceftriaxone; Antibiotic · Organic Chemical
T41	PROC 1659 1670	tratamiento
#34	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	DISO 1697 1707	enfermedad
#35	AnnotatorNotes T42	C0012634; Disease; Disease or Syndrome
T43	DISO 1720 1742	Insuficiencia cardiaca
#36	AnnotatorNotes T43	C0018801; Heart failure; Disease or Syndrome
T44	DISO 1752 1769	cirrosis hepática
#37	AnnotatorNotes T44	C0023890; Liver Cirrhosis; Disease or Syndrome
T45	DISO 1772 1791	insuficiencia renal
#38	AnnotatorNotes T45	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T46	PROC 1805 1828	tratamiento sustitutivo
#39	AnnotatorNotes T46	C0279033; Replacement therapy; Therapeutic or Preventive Procedure
T47	DISO 1882 1895	Shock séptico
#40	AnnotatorNotes T47	C0036983; Septic Shock; Pathologic Function
T48	PROC 1916 1930	aleatorización
#41	AnnotatorNotes T48	C0034656; Randomization; Research Activity
T49	PROC 1934 1945	Tratamiento
#42	AnnotatorNotes T49	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T50	PROC 2064 2075	hemocultivo
#43	AnnotatorNotes T50	C0200949; Blood culture; Laboratory Procedure
T51	PROC 2120 2134	ensayo clínico
#44	AnnotatorNotes T51	C0008976; Clinical Trials; Research Activity
T52	PROC 2139 2150	tratamiento
#45	AnnotatorNotes T52	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T53	PROC 223 299	Ensayo clínico aleatorizado, multicéntrico, abierto, controlado, en fase III
T54	ANAT 411 419	urinaria
#46	AnnotatorNotes T54	C1508753; Urinary system; Body System
T55	DISO 523 573	infección del tracto urinario por Escherichia coli
T56	ANAT 609 617	urinaria
#47	AnnotatorNotes T56	C1508753; Urinary system; Body System
T57	CHEM 846 857	ceftriaxone
#48	AnnotatorNotes T57	C0007561; ceftriaxone; Antibiotic · Organic Chemical
T58	ANAT 1319 1324	renal
#49	AnnotatorNotes T58	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T59	ANAT 1356 1368	vía urinaria
#50	AnnotatorNotes T59	C0042027; Urinary tract; Body Part, Organ, or Organ Component | C1280341; Entire urinary tract; Body System
T60	ANAT 1394 1402	urinaria
#51	AnnotatorNotes T60	C1508753; Urinary system; Body System
T61	ANAT 1482 1487	renal
#52	AnnotatorNotes T61	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T62	ANAT 1503 1508	renal
#53	AnnotatorNotes T62	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T63	CHEM 1543 1554	fosfomicina
#54	AnnotatorNotes T63	C0016610; fosfomycin; Antibiotic · Organic Chemical
T64	ANAT 1734 1742	cardiaca
#55	AnnotatorNotes T64	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T65	ANAT 1761 1769	hepática
#56	AnnotatorNotes T65	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T66	ANAT 1786 1791	renal
#57	AnnotatorNotes T66	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T67	Date 12 16	2013
T68	LIVB 167 183	Escherichia coli
#58	AnnotatorNotes T68	C0014834; Escherichia coli; Bacterium
T69	LIVB 437 453	Escherichia coli
#59	AnnotatorNotes T69	C0014834; Escherichia coli; Bacterium
T70	LIVB 494 503	Bacterias
#60	AnnotatorNotes T70	C0004611; Bacteria; Bacterium
T71	LIVB 557 573	Escherichia coli
#61	AnnotatorNotes T71	C0014834; Escherichia coli; Bacterium
T72	LIVB 635 651	Escherichia coli
#62	AnnotatorNotes T72	C0014834; Escherichia coli; Bacterium
T73	LIVB 697 714	Pacientes adultos
#63	AnnotatorNotes T73	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T75	Age 716 729	18 años o más
T76	LIVB 895 909	microorganismo
#64	AnnotatorNotes T76	C0445623; Microorganism; Organism
T79	Route 1055 1070	vía intravenosa
#65	AnnotatorNotes T79	C1522726; Intravenous Route of Drug Administration; Functional Concept
T80	Duration 1079 1094	al menos 5 días
T81	LIVB 1102 1135	pacientes potencialmente fértiles
#66	AnnotatorNotes T81	C0030705; Patients; Patient or Disabled Group + C4324275; Woman of childbearing potential; Population Group
T84	PHYS 1161 1170	gestación
#67	AnnotatorNotes T84	C0032961; Pregnancy; Organism Function
T85	Neg_cue 1171 1179	negativo
T86	LIVB 1183 1192	Pacientes
#68	AnnotatorNotes T86	C0030705; Patients; Patient or Disabled Group
T87	Neg_cue 1325 1327	no
T89	Duration 1634 1652	inferior a 90 días
T90	PROC 1743 1747	NYHA
#69	AnnotatorNotes T90	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T91	LIVB 1832 1877	Mujeres embarazadas o en periodo de lactancia
#70	AnnotatorNotes T91	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T92	Duration 1962 1971	>72 horas
T93	Duration 1999 2008	>12 horas
T94	LIVB 2036 2043	E. coli
#71	AnnotatorNotes T94	C0014834; Escherichia coli; Bacterium
T95	LIVB 2079 2088	Pacientes
#72	AnnotatorNotes T95	C0030705; Patients; Patient or Disabled Group
T74	LIVB 785 792	E. coli
#73	AnnotatorNotes T74	C0014834; Escherichia coli; Bacterium
T77	PHYS 1840 1851	embarazadas
#74	AnnotatorNotes T77	C0032961; Pregnancy; Organism Function
T78	PHYS 1868 1877	lactancia
#75	AnnotatorNotes T78	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
A1	Population_data T73 Age
A3	Assertion T84 Negated
A4	Assertion T30 Negated
A5	Status T36 History_of
A6	Status T38 History_of
A7	Status T37 History_of
#76	AnnotatorNotes T53	C0206035; Controlled Clinical Trials, Randomized; Research Activity + C1096776; Multicenter Study; Research Activity + C1709323; Open Label Study; Research Activity + C0282461; Phase 3 Clinical Trials; Research Activity
#77	AnnotatorNotes T7	C1096262; Escherichia bacteraemia; Disease or Syndrome 
#78	AnnotatorNotes T13	C0577708; Urinary tract infection caused by Escherichia coli; Disease or Syndrome 
#79	AnnotatorNotes T18	C0577708; Urinary tract infection caused by Escherichia coli; Disease or Syndrome 
#80	AnnotatorNotes T55	C0577708; Urinary tract infection caused by Escherichia coli; Disease or Syndrome 
#81	AnnotatorNotes T16	C0577708; Urinary tract infection caused by Escherichia coli; Disease or Syndrome 
#82	AnnotatorNotes T26	C0455142; Intravenous therapy; Therapeutic or Preventive Procedure | C1273557; Intravenous administration of treatment; Therapeutic or Preventive Procedure
T82	Observation 1372 1380	resuelta
A8	Assertion T82 Negated
#83	AnnotatorNotes T82	C1709863; Recovered or Resolved; Finding
T83	Neg_cue 1369 1371	no
T88	CONC 948 954	origen
A9	Assertion T88 Negated
A10	Assertion T88 Speculated
T96	Neg_cue 939 942	sin
T97	Spec_cue 966 974	probable
T98	Quantifier_or_Qualifier 955 963	evidente
T99	Quantifier_or_Qualifier 1127 1135	fértiles
A11	Assertion T99 Speculated
T100	Spec_cue 1112 1126	potencialmente
R1	Negation Arg1:T96 Arg2:T88	
R2	Speculation Arg1:T97 Arg2:T88	
R3	Has_Quantifier_or_Qualifier Arg1:T88 Arg2:T98	
A12	Assertion T98 Speculated
T101	Quantifier_or_Qualifier 943 947	otro
A13	Assertion T101 Speculated
A14	Assertion T101 Negated
R4	Negation Arg1:T96 Arg2:T101	
R5	Has_Quantifier_or_Qualifier Arg1:T88 Arg2:T101	
R6	Speculation Arg1:T100 Arg2:T99	
R7	Has_Quantifier_or_Qualifier Arg1:T81 Arg2:T99	
R8	Negation Arg1:T85 Arg2:T84	
R9	Negation Arg1:T87 Arg2:T30	
R10	Negation Arg1:T83 Arg2:T82	
R11	Used_for Arg1:T3 Arg2:T6	
R12	Used_for Arg1:T4 Arg2:T6	
R13	Used_for Arg1:T5 Arg2:T6	
R14	Causes Arg1:T68 Arg2:T7	
T102	Quantifier_or_Qualifier 184 200	multirresistente
R15	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T102	
T103	Quantifier_or_Qualifier 454 470	multirresistente
R16	Causes Arg1:T69 Arg2:T13	
R17	Location_of Arg1:T54 Arg2:T13	
R18	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T103	
R19	Location_of Arg1:T15 Arg2:T55	
T104	DISO 494 513	Bacterias en sangre
#84	AnnotatorNotes T104	C0004610; Bacteremia; Disease or Syndrome
R20	Location_of Arg1:T14 Arg2:T104	
R21	Causes Arg1:T55 Arg2:T104	
R22	Causes Arg1:T71 Arg2:T55	
R23	Location_of Arg1:T56 Arg2:T16	
R24	Causes Arg1:T72 Arg2:T16	
T105	Quantifier_or_Qualifier 652 668	multirresistente
R25	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T105	
R26	Has_Age Arg1:T73 Arg2:T75	
R28	Location_of Arg1:T19 Arg2:T18	
R29	Causes Arg1:T74 Arg2:T18	
T106	Quantifier_or_Qualifier 793 808	multiresistente
R30	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T106	
R31	Experiences Arg1:T73 Arg2:T17	
R32	Experiences Arg1:T73 Arg2:T18	
T107	Observation 809 857	sensible a fosfomicina y meropenem o ceftriaxone
R33	Has_Quantifier_or_Qualifier Arg1:T74 Arg2:T107	
R34	Overlap Arg1:T107 Arg2:T20	
R35	Overlap Arg1:T107 Arg2:T21	
R36	Overlap Arg1:T107 Arg2:T57	
T108	CONC 914 928	datos clínicos
#85	AnnotatorNotes T108	C1516606; Clinical Data; Intellectual Product
R38	Causes Arg1:T76 Arg2:T23	
R39	Before Arg1:T88 Arg2:T23	
#86	AnnotatorNotes T88	C0015127; Etiology aspects; Functional Concept | C1314792; Etiology; Functional Concept
R40	Location_of Arg1:T25 Arg2:T24	
R41	Causes Arg1:T24 Arg2:T23	
R42	Causes Arg1:T76 Arg2:T24	
R43	Has_Route_or_Mode Arg1:T26 Arg2:T79	
R44	Has_Duration_or_Interval Arg1:T26 Arg2:T80	
#87	AnnotatorNotes T27	C0032976; Pregnancy Tests; Diagnostic Procedure
R45	Experiences Arg1:T81 Arg2:T27	
R46	Experiences Arg1:T81 Arg2:T84	
R47	Location_of Arg1:T58 Arg2:T29	
R48	Location_of Arg1:T59 Arg2:T31	
R49	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T82	
R50	Location_of Arg1:T60 Arg2:T33	
T109	Observation 1403 1413	hematógena
T110	CONC 1420 1431	contigüidad
#88	AnnotatorNotes T110	C0205283; Contiguous; Spatial Concept
R51	Causes Arg1:T110 Arg2:T33	
R52	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T109	
#89	AnnotatorNotes T109	C0796572; Hematogenous spread; Finding 
R53	Causes Arg1:T63 Arg2:T38	
R54	Causes Arg1:T39 Arg2:T38	
R55	Causes Arg1:T40 Arg2:T38	
R56	Causes Arg1:T63 Arg2:T37	
R57	Causes Arg1:T39 Arg2:T37	
R58	Causes Arg1:T40 Arg2:T37	
R59	Location_of Arg1:T61 Arg2:T35	
R60	Location_of Arg1:T62 Arg2:T36	
T111	Observation 1585 1603	Situación terminal
#90	AnnotatorNotes T111	C2051439; patient condition is terminal; Finding
T112	CONC 1607 1624	esperanza de vida
#91	AnnotatorNotes T112	C0023671; Life Expectancy; Group Attribute
R61	Has_Duration_or_Interval Arg1:T112 Arg2:T89	
T113	Quantifier_or_Qualifier 1681 1690	paliativo
#92	AnnotatorNotes T113	C1285530; Palliative; Qualitative Concept
R62	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T113	
R63	Location_of Arg1:T64 Arg2:T43	
T114	Result_or_Value 1748 1750	IV
R64	Has_Result_or_Value Arg1:T90 Arg2:T114	
R66	Location_of Arg1:T65 Arg2:T44	
R67	Location_of Arg1:T66 Arg2:T45	
R68	Experiences Arg1:T91 Arg2:T77	
R69	Experiences Arg1:T91 Arg2:T78	
R70	Overlap Arg1:T47 Arg2:T48	
R71	Has_Duration_or_Interval Arg1:T49 Arg2:T92	
T115	Quantifier_or_Qualifier 1955 1961	activo
#93	AnnotatorNotes T115	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R72	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T115	
T116	Quantifier_or_Qualifier 1946 1954	empírico
#94	AnnotatorNotes T116	C1880496; Empiric; Qualitative Concept 
R73	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T116	
T117	CONC 1989 1998	inclusión
#95	AnnotatorNotes T117	C1512693; Inclusion; Qualitative Concept
R74	After Arg1:T117 Arg2:T93	
R75	Before Arg1:T50 Arg2:T117	
T118	Quantifier_or_Qualifier 2044 2060	multirresistente
R76	Has_Quantifier_or_Qualifier Arg1:T94 Arg2:T118	
T119	Quantifier_or_Qualifier 1975 1982	Retraso
#96	AnnotatorNotes T119	C0205421; Deferred; Temporal Concept (?)
R77	Has_Quantifier_or_Qualifier Arg1:T117 Arg2:T119	
T120	Observation 2099 2134	participando en otro ensayo clínico
T121	Quantifier_or_Qualifier 2151 2157	activo
#97	AnnotatorNotes T121	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R78	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T121	
R79	Experiences Arg1:T95 Arg2:T52	
R80	Used_for Arg1:T9 Arg2:T12	
R81	Used_for Arg1:T10 Arg2:T12	
R82	Used_for Arg1:T11 Arg2:T12	
R83	Experiences Arg1:T73 Arg2:T107	
R84	Experiences Arg1:T73 Arg2:T20	
R85	Experiences Arg1:T73 Arg2:T21	
R86	Experiences Arg1:T73 Arg2:T57	
#98	AnnotatorNotes T101	C0205394; Other; Qualitative Concept
R27	Negation Arg1:T96 Arg2:T98	
A15	Assertion T98 Speculated
R37	Speculation Arg1:T97 Arg2:T101	
#99	AnnotatorNotes T34	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T122	Quantifier_or_Qualifier 1451 1463	concomitante
#100	AnnotatorNotes T122	C0521115; Simultaneous; Temporal Concept
R87	Has_Quantifier_or_Qualifier Arg1:T34 Arg2:T122	
#101	AnnotatorNotes T98	C5706969; Obvious; Qualitative Concept
A2	Experiencer T73 Patient
A16	Experiencer T81 Patient
A17	Experiencer T86 Patient
A18	Experiencer T91 Patient
A19	Experiencer T95 Patient
T123	Result_or_Value 1171 1179	negativo
R65	Has_Result_or_Value Arg1:T27 Arg2:T123	
